Citation Impact
Citing Papers
Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development
2006 Standout
First-Line Gefitinib for Patients With Advanced Non–Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations Without Indication for Chemotherapy
2009
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Cancer statistics, 2024
2024 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Interrater reliability of cardiac output measurements by transcutaneous Doppler ultrasound: implications for noninvasive hemodynamic monitoring in the ED
2006
ROS in cancer therapy: the bright side of the moon
2020 Standout
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 Standout
Pancreatic cancer
2020 Standout
Regulatory T cells as potential immunotherapy in allergy
2006 StandoutNobel
Environmental and Health Impacts of Air Pollution: A Review
2020 Standout
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial
2014 Standout
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2014 Standout
Disparities in adjuvant treatment of high-grade endometrial cancer in the Medicare population
2021
Colorectal cancer
2019 Standout
FOXP3 and scurfy: how it all began
2014 StandoutNobel
Pyroptosis: mechanisms and diseases
2021 Standout
Cardiorenal Syndrome
2008 Standout
A timeline of tumour-associated macrophage biology
2023
Fadiga relacionada ao câncer: uma revisão
2011 Standout
Gastric cancer
2020 Standout
FOXP3+ regulatory T cells in the human immune system
2010 StandoutNobel
Systematic review of agents for the management of gastrointestinal mucositis in cancer patients
2012
Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403)
2008
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
Investigational cancer drugs targeting cell metabolism in clinical development
2014
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Therapeutic approaches to allergy and autoimmunity based on FoxP3+ regulatory T-cell activation and expansion
2009 StandoutNobel
Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS)
2018 Standout
De novogeneration of antigen-specific CD4+CD25+regulatory T cells from human CD4+CD25–cells
2005
Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients
2006 StandoutNobel
Essential roles of TGF-β in anti-CD3 antibody therapy: reversal of diabetes in nonobese diabetic mice independent of Foxp3+CD4+ regulatory T cells
2007
Erythropoietin or darbepoetin for patients with cancer
2012
Left Ventricular Hypertrophy: Major Risk Factor in Patients with Hypertension: Update and Practical Clinical Applications
2011
Association of Timing of Adjuvant Therapy With Survival in Patients With Resected Stage I to II Pancreatic Cancer
2019
First-SIGNAL: First-Line Single-Agent Iressa Versus Gemcitabine and Cisplatin Trial in Never-Smokers With Adenocarcinoma of the Lung
2012
Works of Sun Yu being referenced
Invasive and noninvasive haemodynamic monitoring of acutely ill sepsis and septic shock patients in the emergency department
2000
Effect of carvedilol on coronary flow reserve in patients with hypertensive left-ventricular hypertrophy
2009
Randomized phase 2 study of subcutaneous amifostine versus epoetin‐α given 3 times weekly during concurrent chemotherapy and hyperfractionated radiotherapy for limited‐disease small cell lung cancer
2008
Impact of timing of adjuvant chemotherapy on survival in stage III colon cancer: a population-based study
2018
Macrophage spatial heterogeneity in gastric cancer defined by multiplex immunohistochemistry
2019
A phase 2 study of irinotecan, cisplatin, and simvastatin for untreated extensive‐disease small cell lung cancer
2010
Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-β?
2004
The Role of Gefitinib Treatment for Korean Never-Smokers with Advanced or Metastatic Adenocarcinoma of the Lung: A Prospective Study
2006
What has preoperative radio(chemo)therapy brought to localized rectal cancer patients in terms of perioperative and long‐term outcomes over the past decades? A systematic review and meta‐analysis based on 41,121 patients
2017
The Role of Gefitinib Treatment for Korean Never-Smokers with Advanced or Metastatic Adenocarcinoma of the Lung: A Prospective Study
2006